Guido Bhatt

Guido Bhatt focuses on late effects of testicular cancer treatment in the large and growing survivor population cured by chemotherapy and radiation. His research has characterized cardiovascular morbidity, metabolic syndrome, fertility impairment, and second malignancy risks in testicular cancer survivors. He has identified specific chemotherapy and radiation dose factors that predict long-term toxicities, enabling risk-stratified follow-up protocols. His survivorship research is crucial for the millions of young men cured of testicular cancer who face decades of living with treatment consequences.